மதிப்புமிக்கது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மதிப்புமிக்கது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மதிப்புமிக்கது Today - Breaking & Trending Today

Welcome To IANS Live - ENTERTAINMENT - TV actor Hitanshu Jinsi: Imparting tales of wisdom to viewers is a surreal feeling

Last week, the series showcased the story of Bedi Walle Hanuman and its significance at the Jagannath Puri temple. Continuing the tales of Jagannath Puri, this week viewers will learn about the tradition of Rathyatra, how a devotee of Lord Jagannath learns an important lesson and what led to the auspicious day of Ganesha Vesha.Hita ....

Hitanshu Jinsi , Dakul Seth , Vighnaharta Ganesh , News Service , India Private , Actor Hitanshu Jinsi , Lord Jagannath , All Rights , ஹிட்டன்ஷு ஜின்சி , விக்ஹர்த்த கணேஷ் , செய்தி சேவை , இந்தியா ப்ரைவேட் , ஆண்டவர் ஜெகந்நாத் , அனைத்தும் உரிமைகள் ,

NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination With Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% of Evaluable Patients Regardless of Prior Anti-PD-1 Exposure


NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination With Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% of Evaluable Patients Regardless of Prior Anti-PD-1 Exposure
Results show NBTXR3 plus radiotherapy could potentially stimulate immune response and convert anti-PD-1 non-responders into responders
Objective response was observed in 60% of anti-PD-1 naïve patients and 50% of prior non-responders
Data suggest abscopal effect in some patients (i.e., reduction in non-injected non-irradiated lesions)
To date, the overall adverse event profile for the 16 injected patients has not differed from what is expected with radiotherapy or anti-PD-1 agents (head and neck cancer and non-small cell lung cancer primary tumors) ....

New York , United States , France General , United Kingdom , Brandon Owens , Kate Mcneil , Colette Shen , Porter Novelli , Tanguy Seiwert , Pierre Louis Germain , Exchange Commission On , University Of Texas Md Anderson Cancer Center , French Financial Markets Authority Autorit , Drug Administration , Nanobiotix Communications , Given The Company , American Society , Eastern Time , European Time , Business Wire , Clinical Oncology , Johns Hopkins , Laurent Levy , Immune Response , Phasei Study , Advanced Cancers Treated ,